Announcing a new publication for BIO Integration journal. In this review article the authors Zeling Guo, Shanping Jiang, Zilun Li and Sifan Chen from Sun Yat-Sen University, Guangzhou, China review how metabolic syndrome "interacts" with COVID-19.
Coronavirus disease 2019 (COVID-19) has rapidly spread worldwide and has exerted a great influence on public health and society. Metabolic disturbance involving various organs has been found in COVID-19 patients, including diabetes, fatty liver and acute kidney injury (AKI). In turn, pre-existing metabolic syndromes could exacerbate the effects of COVID-19. In this review, the authors focus on the close interaction between COVID-19 and metabolic syndrome, as well as the potential of repurposing metabolic-related drugs and the importance of treating metabolic diseases in COVID-19 patients.